|
1
|
Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A.
|
J Immunol
|
2000
|
3.74
|
|
2
|
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.
|
J Immunol
|
1998
|
2.94
|
|
3
|
Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry.
|
Cytometry
|
1999
|
2.87
|
|
4
|
Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan.
|
Am J Trop Med Hyg
|
1996
|
2.72
|
|
5
|
Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria.
|
Lancet
|
1998
|
2.39
|
|
6
|
Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.
|
Infect Immun
|
1999
|
2.16
|
|
7
|
Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.
|
J Infect Dis
|
2001
|
2.15
|
|
8
|
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response.
|
Clin Exp Immunol
|
1992
|
1.98
|
|
9
|
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections.
|
Immunol Lett
|
2000
|
1.89
|
|
10
|
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.
|
J Infect Dis
|
2000
|
1.76
|
|
11
|
Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children.
|
Infect Immun
|
2001
|
1.69
|
|
12
|
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria.
|
Immunology
|
1993
|
1.64
|
|
13
|
Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes.
|
Infect Immun
|
1999
|
1.59
|
|
14
|
Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.
|
Immunology
|
1994
|
1.55
|
|
15
|
The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission.
|
Trans R Soc Trop Med Hyg
|
2001
|
1.53
|
|
16
|
Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren.
|
Trans R Soc Trop Med Hyg
|
2000
|
1.49
|
|
17
|
Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village.
|
Parasitology
|
1998
|
1.48
|
|
18
|
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.
|
Infect Immun
|
2001
|
1.44
|
|
19
|
Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmodium falciparum malaria.
|
Am J Trop Med Hyg
|
1994
|
1.42
|
|
20
|
Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria.
|
Br J Haematol
|
1997
|
1.41
|
|
21
|
Structure-activity studies: in vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida.
|
Planta Med
|
1999
|
1.24
|
|
22
|
What is the cause of lymphopenia in malaria?
|
Infect Immun
|
2000
|
1.23
|
|
23
|
The Role of Variant-specific Immunity in Asymptomatic Malaria Infections: Maintaining a Fine Balance.
|
Parasitol Today
|
1998
|
1.22
|
|
24
|
Overlapping antigenic repertoires of variant antigens expressed on the surface of erythrocytes infected by Plasmodium falciparum.
|
Parasitology
|
1999
|
1.21
|
|
25
|
Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
|
Eur Cytokine Netw
|
2000
|
1.17
|
|
26
|
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
|
Antimicrob Agents Chemother
|
1994
|
1.16
|
|
27
|
Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes.
|
Am J Trop Med Hyg
|
1998
|
1.15
|
|
28
|
Alkamides from Phyllanthus fraternus.
|
Planta Med
|
1998
|
1.15
|
|
29
|
Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis.
|
Scand J Immunol
|
1999
|
1.11
|
|
30
|
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.
|
Infect Immun
|
2001
|
1.10
|
|
31
|
Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria.
|
Trans R Soc Trop Med Hyg
|
2001
|
1.05
|
|
32
|
Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria.
|
Trans R Soc Trop Med Hyg
|
2000
|
1.04
|
|
33
|
High proportion of subclinical Plasmodium falciparum infections in an area of seasonal and unstable malaria in Sudan.
|
Am J Trop Med Hyg
|
1995
|
1.04
|
|
34
|
Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum.
|
Infect Immun
|
1993
|
1.04
|
|
35
|
Pregnancy-associated malaria in a rural community of ghana.
|
Ghana Med J
|
2009
|
1.04
|
|
36
|
A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.
|
Infect Immun
|
1999
|
1.03
|
|
37
|
Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria.
|
Clin Exp Immunol
|
2002
|
1.01
|
|
38
|
Activation of human T lymphocytes by Leishmania lipophosphoglycan.
|
Scand J Immunol
|
1991
|
1.01
|
|
39
|
Cell-mediated immune responses to Plasmodium falciparum purified soluble antigens in sickle-cell trait subjects.
|
Immunol Lett
|
1990
|
1.00
|
|
40
|
Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.
|
Clin Exp Immunol
|
1999
|
1.00
|
|
41
|
Cell-mediated immunity to Plasmodium falciparum infection: evidence against the involvement of cytotoxic lymphocytes.
|
Scand J Immunol
|
1988
|
0.99
|
|
42
|
Antibody responses to Rhoptry-Associated Protein-1 (RAP-1) of Plasmodium falciparum parasites in humans from areas of different malaria endemicity.
|
Parasite Immunol
|
1997
|
0.98
|
|
43
|
Increased eosinophil activity in acute Plasmodium falciparum infection--association with cerebral malaria.
|
Clin Exp Immunol
|
1998
|
0.98
|
|
44
|
Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.
|
Clin Exp Immunol
|
1994
|
0.95
|
|
45
|
West African donors have high percentages of activated cytokine producing T cells that are prone to apoptosis.
|
Clin Exp Immunol
|
2001
|
0.95
|
|
46
|
Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major.
|
Scand J Immunol
|
1997
|
0.93
|
|
47
|
Insecticide-treated bed nets reduce plasma antibody levels and limit the repertoire of antibodies to Plasmodium falciparum variant surface antigens.
|
Clin Diagn Lab Immunol
|
2001
|
0.90
|
|
48
|
Seasonal changes in cell mediated immune responses to soluble Plasmodium falciparum antigens in children with haemoglobin AA and haemoglobin AS.
|
Trans R Soc Trop Med Hyg
|
1992
|
0.88
|
|
49
|
The cytokine balance in severe malarial anemia.
|
J Infect Dis
|
1999
|
0.88
|
|
50
|
Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens.
|
Parasite Immunol
|
2009
|
0.88
|
|
51
|
Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals.
|
Clin Exp Immunol
|
1992
|
0.87
|
|
52
|
The importance of strict patient definition in studies of malaria pathogenesis.
|
Trends Parasitol
|
2001
|
0.86
|
|
53
|
The major surface glycoprotein (gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells.
|
J Immunol
|
1994
|
0.86
|
|
54
|
Human T-cell recognition of synthetic peptides representing conserved and variant sequences from the merozoite surface protein 2 of Plasmodium falciparum.
|
Immunol Lett
|
1997
|
0.83
|
|
55
|
Lymphoproliferative responses to Plasmodium falciparum antigens in children with and without the sickle cell trait.
|
Scand J Immunol
|
1991
|
0.81
|
|
56
|
Reduced cellular immune reactivity in healthy individuals during the malaria transmission season.
|
Immunol Lett
|
1990
|
0.81
|
|
57
|
Soluble haemoglobin is a marker of recent Plasmodium falciparum infections.
|
Immunol Lett
|
1997
|
0.79
|
|
58
|
Biochemical characterization, localization and immunostimulating properties of a soluble glycoprotein, Ag1, isolated from in vitro cultures of Plasmodium falciparum.
|
Parasitol Res
|
1990
|
0.75
|
|
59
|
Isolation and characterization of a soluble antigen complex of Plasmodium falciparum with pyrogenic properties.
|
APMIS
|
1991
|
0.75
|
|
60
|
Antibody reactivities to glutamate-rich peptides of Plasmodium falciparum parasites in humans from areas of different malaria endemicity.
|
APMIS
|
1996
|
0.75
|